Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Credit agrmnt [a]
Director departure
Employment agrmnt
Auditor change
|
|
UFP TECHNOLOGIES INC (UFPT)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/04/2023 |
8-K
| Quarterly results|
Docs:
|
"UFP Technologies Announces Record Q2 Results NEWBURYPORT, Mass., Aug. 01, 2023 -- UFP Technologies, Inc. , an innovative designer and custom manufacturer of components, subassemblies, products, and packaging primarily for the medical market, today reported net income of $11.9 million or $1.55 per diluted common share outstanding for its second quarter ended June 30, 2023, compared to net income of $8.9 million or $1.17 per diluted common share outstanding for the same quarter in 2022. Sales for the second quarter were $100.0 million compared to sales of $94.3 million in the second quarter of 2022. Net income for the six-month period ended June 30, 2023 was $21.6 million or $2.81 per diluted common share outstanding compared to $13.8 million or $1.81 per diluted common share outstanding for..." |
|
| 08/03/2022 |
8-K
| Quarterly results |
| 05/09/2022 |
8-K
| Quarterly results |
| 08/05/2021 |
8-K
| Quarterly results |
| 05/04/2021 |
8-K
| Quarterly results |
| 03/08/2021 |
8-K
| Quarterly results |
| 11/03/2020 |
8-K
| Quarterly results|
Docs:
|
"UFP Technologies Announces Q3 Results NEWBURYPORT, Mass., Nov. 03, 2020 -- UFP Technologies, Inc. , an innovative designer and custom manufacturer of components, subassemblies, products, and packaging primarily for the medical market, today reported net income of $3.0 million or $0.40 per diluted common share outstanding for its third quarter ended September 30, 2020, compared to net income of $5.6 million or $0.75 per diluted common share outstanding for the same period in 2019. Sales for the third quarter were $43.3 million compared to third quarter sales of $49.4 million in 2019. Net income for the nine-month period ended September 30, 2020 was $9.2 million or $1.22 per diluted common share outstanding compared to $14.0 million or $1.87 per diluted common share outstanding for the same ..." |
|
| 08/05/2020 |
8-K
| Quarterly results |
| 05/05/2020 |
8-K
| Quarterly results |
| 03/05/2020 |
8-K
| Quarterly results |
| 11/06/2019 |
8-K
| Quarterly results |
| 08/07/2019 |
8-K
| Quarterly results |
| 05/07/2019 |
8-K
| Quarterly results |
| 03/08/2019 |
8-K
| Quarterly results |
| 11/01/2018 |
8-K
| Quarterly results |
| 08/02/2018 |
8-K
| Quarterly results |
| 05/07/2018 |
8-K
| Quarterly results |
| 03/01/2018 |
8-K
| Quarterly results |
| 11/02/2017 |
8-K
| Quarterly results |
| 08/02/2017 |
8-K
| Quarterly results |
| 05/05/2017 |
8-K
| Form 8-K - Current report |
| 03/03/2017 |
8-K
| Form 8-K - Current report |
| 11/03/2016 |
8-K
| Quarterly results |
| 08/03/2016 |
8-K
| Form 8-K - Current report |
| 05/05/2016 |
8-K
| Form 8-K - Current report |
| 03/02/2016 |
8-K
| Form 8-K - Current report |
| 11/05/2015 |
8-K
| Form 8-K - Current report |
| 08/05/2015 |
8-K
| Form 8-K - Current report |
| 05/06/2015 |
8-K
| Form 8-K - Current report |
| 03/04/2015 |
8-K
| Form 8-K - Current report |
| 11/05/2014 |
8-K
| Form 8-K - Current report |
| 08/06/2014 |
8-K
| Form 8-K - Current report |
| 05/06/2014 |
8-K
| Form 8-K - Current report |
| 02/27/2014 |
8-K
| Form 8-K - Current report |
|
|
|